Research Use Disclaimer

You must be 21 or older. Agree to the following terms before accessing product information and pricing.

Research Use Policy Summary

You are 21 years of age or older
All products sold exclusively for laboratory research purposes
Products are not intended for human consumption, diagnosis, or therapeutic use
Purchasers must be qualified researchers or licensed professionals
These products have not been evaluated or approved by the FDA
All sales are final and subject to our research use terms

For laboratory research use only. Not for human or veterinary consumption, diagnostic use, therapeutic use, or clinical use.

Read full Research Use Disclaimer (opens in new tab) →

Product Usage Notice · This product is intended strictly for research and laboratory use only. It is designated for in vitro testing and experimental purposes. Any use involving human or animal consumption is prohibited by law. All information provided on this website is for educational purposes only. This product must only be handled by licensed, qualified professionals. It is not intended for use as a drug, food, or cosmetic, and must not be misused, mislabeled, or misrepresented as such. Read full Research Use Policy →

Compound Information

Technical specifications

Molecular Profile

What Is Sermorelin?

Sermorelin is a synthetic 29-amino acid analog of endogenous GHRH(1-44), used in research to stimulate pituitary growth hormone release.

Type: Peptide
CAS Number: 86168-78-7
Molecular Weight: 3357.9 g/mol
Amino Acids: 29 residues
Sequence: Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2
Formula: C149H246N44O42S

PubChem Database

SERMORELIN · 1997

Endocrine and Metabolic Pathway Effects of Growth Hormone-Releasing Hormone-(1-29)-NH2 Journal of Endocrinology & Metabolism Published pharmacology literature examining GHRH analog receptor signaling. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.

View Study

SERMORELIN · 2006

Sermorelin and GHRH Analog Signaling Mechanisms published pharmacology Interventions in Aging Published pharmacological analysis comparing GHRH analog signaling mechanisms. Cited for scientific context describing pulsatile GH secretion biology studied in the literature; does not provide use guidance or product claims for this research compound.

View Study

SERMORELIN · 2020

Beyond the Androgen Receptor: Growth Hormone Secretagogue Signaling Mechanisms Translational Andrology and Urology Review examining GHS pharmacology and signaling mechanisms in published literature. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.

View Study

SERMORELIN · 1997

Sermorelin Reference Compound Research in GH Axis Pathway Readouts Growth Hormone & IGF Research Published pharmacology literature examining sermorelin as a research reference compound for GHRH receptor signaling assessment. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.

View Study

SERMORELIN · 2008

GHRH Analog Research in Metabolic Pathway and Receptor Pharmacology Endocrinology Published study examining GHRH receptor pharmacology in a published pharmacology setting. Cited for scientific context only; it does not provide use guidance or product claims for this research compound.

View Study

SERMORELIN · 2010

Growth Hormone Releasing Hormone (GHRH) Neurons and GHRH-Neuron Subtypes in the Hypothalamus Frontiers in Neuroendocrinology Neuroanatomical study mapping GHRH neuronal circuits and pulsatile GH secretion mechanisms, providing mechanistic context for GHRH analog pharmacology research.

View Study